Microbiome profiling reveals associations with ulcerative colitis severity, treatment

October 11, 2018 by Tom Ulrich, Broad Institute of MIT and Harvard
Microbiome profiling reveals associations with ulcerative colitis severity, treatment
Credit : Susanna M. Hamilton, Broad Communications

A study of gut microbes from more than 400 children points to how the microbiome behaves in this inflammatory bowel disease.

The gastrointestinal tract hosts a complicated set of relationships involving a variety of host cells (e.g., epithelial cells, immune cells) and the array of that make their home inside the gut (collectively known as the ). In ulcerative colitis (UC) and Crohn's , those relationships are interrupted by mechanisms that researchers do not yet fully grasp, but in which the may play a critical role.

To better understand where microbes fit in UC progression and treatment, a multicenter team led by computational scientist Melanie Schirmer and core institute member Ramnik Xavier of the Broad's Infectious Disease and Microbiome Program (IDMP) profiled the gut microbiomes of 405 children with UC for a year after diagnosis.

By bringing comprehensive health records together with 16s rRNA amplicon sequencing—a sequencing approach that gives a snapshot of all microbes within a sample—of patient stool and gut biopsies, the team found clear patterns in microbiome composition that tracked over time with disease severity and treatment response. They reported their findings in Cell Host & Microbe.

"Most of the microbiome profiling work related to has focused on patients on treatment," said Xavier, who co-directs both the IDMP and the Center for Microbiome Informatics and Therapeutics (CMIT) at the Massachusetts Institute of Technology. He also directs the Center for Computational and Integrative Biology at Massachusetts General Hospital. "This study has helped reveal features of the treatment-naïve microbiome in pediatric UC, and identify links between the microbiome and refractory disease."

All told, the researchers linked the abundance of 50 microbial organisms with disease severity at diagnosis. They also found that changes in microbial abundances over time associated with whether or not a child's disease responded to standard therapies. This included the surprising finding that microbiomes from children with severe UC were unusually rich in bacteria normally found in the mouth, which exacerbate inflammation in UC patients.

The team also noted that the levels of certain microbe-targeting antibodies changed in UC patients. These changes also tracked with , and suggested that interactions between the immune system and certain may influence whether a child's disease gets worse or improves over time.

The authors pointed out that they cannot say whether the patterns they found help cause UC. However, their findings suggest that microbiomes might serve as therapeutic resources for UC treatment, as biomarkers for forecasting a patient's clinical course, and for planning and monitoring care.

Schirmer and Xavier's team carried out their analysis under the auspices of PROTECT, a National Institutes of Health-supported study aimed at providing a better understanding of how children newly diagnosed with UC respond to standard initial therapies.

Explore further: First gut bacteria may have lasting effect on ability to fight chronic diseases

More information: Melanie Schirmer et al. Compositional and Temporal Changes in the Gut Microbiome of Pediatric Ulcerative Colitis Patients Are Linked to Disease Course, Cell Host & Microbe (2018). DOI: 10.1016/j.chom.2018.09.009

Related Stories

First gut bacteria may have lasting effect on ability to fight chronic diseases

September 18, 2018
New research showing that the first bacteria introduced into the gut have a lasting impact may one day allow science to adjust microbiomes—the one-of-a-kind microbial communities that live in our gastrointestinal tracts—to ...

Gut microbiomes may hold clues to IBD treatment's likelihood of success

May 11, 2017
The constitution of an IBD patient's microbiome may help predict whether treatment with a therapeutic antibody will prove fruitful, according to an early-stage study.

Microbiomes more in flux in patients with inflammatory bowel disease

February 13, 2017
Patients with inflammatory bowel disease are more likely to see dramatic shifts in the make-up of the community of microbes in their gut than healthy people, according to the results of a study published online Feb. 13 in ...

Newly diagnosed Crohn's disease patients show imbalance in intestinal microbial population

March 12, 2014
A multi-institutional study led by investigators from Massachusetts General Hospital (MGH) and the Broad Institute has identified how the intestinal microbial population of newly diagnosed Crohn's disease patients differs ...

Changes in gut microbiome in only one subset of helminth-infected patients

August 9, 2018
Over the last decade, it's become clearer than ever that bacteria in the human gut— collectively termed the microbiome—play a key role in health and disease. Now, researchers reporting in PLOS Neglected Tropical Diseases ...

Recommended for you

A new mechanism in the control of inflammation

October 18, 2018
After infection or tissue injury, the inflammatory immune response attacks the infection and repairs the damaged tissue. However, sometimes excess inflammation can have the opposite effect, increasing injury in a process ...

Sugar, a 'sweet' tool to understand brain injuries

October 15, 2018
Australian researchers have developed ground-breaking new technology which could prove crucial in treating brain injuries and have multiple other applications, including testing the success of cancer therapies.

Scientists reveal new cystic fibrosis treatments work best in inflamed airways

October 11, 2018
A new UNC School of Medicine study shows that two cystic fibrosis (CF) drugs aimed at correcting the defected CFTR protein seem to be more effective when a patient's airway is inflamed. This is the first study to evaluate ...

Microbiome profiling reveals associations with ulcerative colitis severity, treatment

October 11, 2018
A study of gut microbes from more than 400 children points to how the microbiome behaves in this inflammatory bowel disease.

Genomic study finds a new role for microRNAs as predictors of Crohn's disease progression

October 4, 2018
Crohn's disease is a lifelong condition characterized by a fluctuating course of gastro-intestinal inflammation with repeated flares and remissions. Any part of the alimentary tract from the mouth to the anus can be affected ...

Immune system's balancing act keeps bowel disease in check

October 2, 2018
Australian researchers have uncovered clues in the immune system that reveal how the balance of 'good' gut bacteria is maintained. The information could help in the prevention and treatment of inflammatory bowel disease (IBD).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.